[1] Uwaezuoke SN, Ayuk AC, Eze JN.Severe bronchial asthma in children:a review of novel biomarkers used as predictors of the disease[J].J Asthma Allergy,2018,11:11-18. [2] Hayashi F, Hayashi S,Matsuse D, et al.Hopkins syndrome following the first episode of bronchial asthma associated with enterovirus D68:a case report[J].BMC Neurology,2018,18(1):71. [3] Li F, Zhu Y,Xie X, et al.Interleukin-12B gene polymorphisms and bronchial asthma risk:a meta-analysis[J].J Asthma,2017,54(8):777-783. [4] Elmaraghy MA, Hodieb MM, Khattab RAER, et al.Association between TSLP gene polymorphism and bronchial asthma in children in Beni Suef Governorate in Egypt[J].Comp Clin Pathol,2018,27(3):565-570. [5] Borel P, Desmarchelier C, Nowicki M, et al.A combination of single-nucleotide polymorphisms is associated with interindividual variability in dietary β-carotene bioavailability in healthy men[J].J Nutr,2015,145(8):1740-1747. [6] Chen S, Wang Y, Yu C, et al.Investigation of cytotoxic T-lymphocyte antigen-4polymorphisms in non-small cell lung cancer:a case-control study[J].Oncotarget,2017,8(44):76634-76643. [7] Tian L,Xie XH, Zhu ZH.Calotropin regulates the apoptosis of non small cell cancer by regulating the cytotoxic T lymphocyte associated antigen 4 mediated TGF β/ERK signaling pathway[J].Mol Med Rep,2018,17(6):7683-7691. [8] Zhang F,Rong Z, Wang Z, et al.Periostin promotes ectopic osteogenesis of CTLA4-modified bone marrow mesenchymal stem cells[J].Cell Tissue Res,2017,370(1):143-151. [9] Sueda S, Nakayama S, Adachi T, et al.Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma[J].Ann Hematol,2019,98(1):235-236. [10] 中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志,2016,39(9):675-697. [11]Wei SC, Levine JH, Cogdill AP, et al.Distinct cellular mechanisms underlie Anti-CTLA-4 and Anti-PD-1 checkpoint blockade[J].Cell,2017,170(6):1120-1133. [12] Zhang Y, Zhang S, Xia W, et al.Association of cytotoxic T-lymphocyte antigen 4 rs231775 gene polymorphism with colorectal cancer risk[J].J Cancer ResTher,2018,14(Suppl):526-532. [13] Zhang C, Peng Y,Hublitz P, et al.Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy[J].Sci Rep-UK,2018,8(1):5549. [14] Tian L,Xie XH, Zhu ZH.Calotropin regulates the apoptosis of non small cell cancer by regulating the cytotoxic T lymphocyte associated antigen 4 mediated TGF β/ERK signaling pathway[J].Mol Med Rep,2018,17(6):7683-7691. [15] Shih YL, Lu HF, Hsiao CW, et al.Distribution of cytotoxic T lymphocyte-associated antigen-4 promoter polymorphisms in Taiwanese patients with type 2 diabetes mellitus[J].Int J Med Sci,2018,15(4):395-402. [16] Durgeau A, Virk Y, Corgnac S, et al.Recent advances in targeting CD8 T-cell immunity for more effective cancer immunotherapy[J].Front Immunol,2018,9:14. [17] Mishra OP, Chhabra P, Narayan G, et al.Cytotoxic T-lymphocyte antigen-4 (CTLA4) gene expression and urinary CTLA4 levels in idiopathic nephrotic syndrome[J].Indian J Pediatr,2019,86(1):26-31. [18] Wang P, Zhao P, Dong S, et al.An albumin-binding polypeptide both targets cytotoxic T lymphocyte vaccines to lymph nodes and boosts vaccine presentation by dendritic cells[J].Theranostics,2018,8(1):223-236. [19] Zheng Y, Wang H, Luo L, et al.A meta-analysis of the association between CTLA-4 genetic polymorphism and susceptibility of asthma[J].Medicine,2018,97(28):e11380. [20] Zhang Y, Sun E, Li X, et al.miR-155 contributes to Df1-induced asthma by increasing the proliferative response ofTh cells via CTLA-4 downregulation[J].Cell Immunol,2017,314:1-9. |